GrowingStockReport.com

NASDAQ Active Stock Watch List: CytRx Corporation (NASDAQ:CYTR) and Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/26/2013 -- -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding CytRx Corporation (NASDAQ:CYTR) and Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR).

CytRx Corporation (NASDAQ:CYTR) a biopharmaceutical research and development company specializing in oncology is currently down (-4.96%) on 1,161,576 shares traded after TheStreet Quant Ratings rated CytRx Corporation as a sell. CytRx Corporation (NASDAQ:CYTR) is currently down (-33.28%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about CytRx Corporation (NASDAQ:CYTR)

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) a biopharmaceutical company that provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications is currently up (+1.50%) on 810,230 shares traded. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is currently up (+121.74%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com